Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 4,166 | 3,040 | 1,700 | 2,672 | 1,616 |
Cost of Goods | 3,057 | 1,972 | 1,116 | 941 | 516 |
Gross Profit | 1,109 | 1,067 | 584 | 1,731 | 1,100 |
Operating Expenses | 5,872 | 6,658 | 4,142 | 4,988 | 4,589 |
Operating Income | -4,707 | -4,618 | -3,442 | -2,316 | -2,973 |
Interest Expense | 0 | 0 | 0 | 0 | -5 |
Other Income | -14 | 110 | -5 | 799 | -1,839 |
Pre-tax Income | -4,721 | -4,508 | -3,447 | -1,517 | -4,807 |
Net Income Continuous | -4,721 | -4,508 | -3,447 | -1,517 | -4,807 |
Minority Interests | -1 | 8 | 2 | 0 | -3 |
Net Income | $-4,720 | $-4,516 | $-3,449 | $-1,517 | $-4,805 |
EPS Basic Total Ops | -12.60 | -10.00 | -9.60 | -4.20 | -17.60 |
EPS Basic Continuous Ops | -12.61 | -9.95 | -9.53 | -4.19 | -17.61 |
EPS Diluted Total Ops | -12.60 | -10.00 | -9.60 | -4.20 | -17.60 |
EPS Diluted Continuous Ops | -12.61 | -9.95 | -9.53 | -4.19 | -17.61 |
EBITDA(a) | $-4,386 | $-4,318 | $-3,194 | $-2,117 | $-2,876 |